Evidence map›Paper›PMID 33106234›Full record

ArticleDisease models & mechanisms2020

Xinrui Wang, Amelia Lauth, Tina C Wan, John W Lough, John A Auchampach

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. American journal of physiology. Heart and circulatory physiology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  14. Article
  15. Corticosteroid Receptors in Cardiac Health and Disease.Advances in experimental medicine and biology · 2022
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xinrui WangDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Amelia LauthCardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Tina C WanDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
John W LoughCardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
John A AuchampachDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA jauchamp@mcw.edu.ORCID 0000-0002-8005-4599

Funding

Tip60, Ischemic Heart Disease and RegenerationR01HL131788 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI AUCHAMPACH, JOHN A, LOUGH, JOHN W · 2017 to 2020
$2.0M
Adenosine Signaling During Post-Infarction Remodeling and Heart FailureR01HL133589 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI AUCHAMPACH, JOHN A · 2017 to 2020
$1.7M
VisualSonics Vevo 3100 High-Frequency Ultrasound Imaging SystemS10OD025038 · OD · MEDICAL COLLEGE OF WISCONSIN · PI AUCHAMPACH, JOHN A · 2019 to 2019
$302k
NHLBI NIH HHS R01 HL131788NHLBI NIH HHS R01 HL133589NIH HHS S10 OD025038
6 · The paper itself

Abstract

Regeneration of muscle in the damaged myocardium is a major objective of cardiovascular research, for which purpose many investigators utilize mice containing transgenes encoding Cre recombinase to recombine loxP-flanked target genes. An unfortunate side effect of the Cre-loxP model is the propensity of Cre recombinase to inflict off-target DNA damage, which has been documented in various eukaryotic cell types including cardiomyocytes (CMs). In the heart, reported effects of Cre recombinase include contractile dysfunction, fibrosis, cellular infiltration and induction of the DNA damage response (DDR). During experiments on adult mice containing a widely used

Indexed as

Cell CycleDNA DamageAnimalsApoptosisBiomarkersDNA RepairElectrocardiographyGene Expression RegulationInflammationIntegrasesMice, Inbred C57BLMice, TransgenicMyocardial InfarctionMyocardiumMyocytes, CardiacMyosin Heavy ChainsBiomarkersCre recombinaseIntegrasesMyh6 protein, mouseMyosin Heavy ChainsRNA, MessengerTamoxifenApoptosisCell cycleConditional gene deletionCre recombinaseDNA damage responseFetal marker genesMerCremerTransgenic animals

Identifiers

PMID33106234
PMCPMC7758623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.